XORTX Shareholders Back 5-to-1 Consolidation to Avert NASDAQ Delisting
XORTX shareholders approved a 5-to-1 share consolidation to maintain NASDAQ compliance, reducing shares from 6.96M to 1.39M ahead of April 2026 deadline.
XRTXkidney diseaseshare consolidation